Thursday's early movers: AXP, TMUS, PTC >>> READ MORE


Vanguard Sector Funds

These four low-cost Vanguard sector funds can be smart choices to strengthen your portfolio with tactical exposure. More 

Valeant Pharmaceuticals Tanks on Ackman Exit Reports (VRX)

Bill Ackman's two-year relationship with Valeant Pharmaceuticals (VRX) reportedly is at an end, with the activist exiting VRX stock Monday. More 

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Is a Good Spec Buy

Teva Pharmaceutical (TEVA) needs the right leadership and a new strategy, but assets make TEVA stock enticing as a gamble. More 

3 Drug Stocks Hit by Trump’s Call for Lower Prices

While stocks in general are looking weak, pharmaceutical stocks in particular are getting hit. Here are three large-cap drug stocks to avoid. More 

Teva Pharmaceuticals Industries Ltd (ADR) (TEVA): Be Cautious and Earn a Double-Digit Return

There’s reasons to see Teva Pharmaceuticals (TEVA) as attractively priced, but a credit put spread trumps owning TEVA stock for the time being. More 

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is CRAZY Cheap

Teva Pharmaceutical's (TEVA) turnaround hopes and cheap multiple are attractive right now. TEVA stock has risks, but the reward is tempting. More 

Zeltiq Aesthetics Inc (ZLTQ) Stock Soars on$2.5B Allergan (AGN) Deal

Zeltiq Aesthetics Inc (ZLTQ) stock was up on Monday following news that Allergan plc Ordinary Shares (AGN) will acquire it. More